Suppr超能文献

埃及医生对肝细胞癌的筛查。

Screening for hepatocellular carcinoma by Egyptian physicians.

作者信息

Hassany Sahar M, Moustafa Ehab F Abdou, Taher Mohamed El, Abdeltwab Afaf Adel, Blum Hubert E

机构信息

Sahar M Hassany, Ehab F Abdou Moustafa, Mohamed El Taher, Department of Tropical Medicine and Gastroenterology, Assiut University, Assiut 71526, Egypt.

出版信息

World J Gastrointest Oncol. 2015 Sep 15;7(9):161-71. doi: 10.4251/wjgo.v7.i9.161.

Abstract

AIM

To assess the practice of Egyptian physicians in screening patients for hepatocellular carcinoma (HCC).

METHODS

The study included 154 physicians from all over Egypt caring for patients at risk for HCC. The study was based on a questionnaire with 20 items. Each questionnaire consisted of two parts: (1) personal information regarding the physician (name, age, specialty and type of health care setting); and (2) professional experience in the care of patients at risk for HCC development (screening, knowledge about the cause and natural course of liver diseases and HCC risk).

RESULTS

Sixty-eight percent of doctors with an MD degree, 48% of doctors with a master degree or a diploma and 40% of doctors with a Bachelor of Medicine, Bachelor of Surgery certificate considered the hepatitis C virus (HCV) genotype as risk factor for HCC development (P < 0.05). Ninety percent of physicians specialized in tropical medicine, internal medicine or gastroenterology and 67% of physicians in other specialties advise patients to undergo screening for HCV and hepatitis B virus infection as well as liver cirrhosis (P < 0.05). Eighty-six percent of doctors in University Hospitals and 69% of Ministry of Health (MOH) doctors consider HCV infection as the leading cause of HCC in Egypt (P < 0.05). Seventy-two percent of doctors with an MD degree, 55% of doctors with a master degree or a diploma, 56% of doctors with an MBBCH certificate, 74% of doctors in University Hospitals and 46% of MOH hospital doctors consider abdominal ultrasonography as the most important investigation in HCC screening (P < 0.05). Sixty-five percent of physicians in tropical medicine, internal medicine or gastroenterology and 37% of physicians in other specialties recommend as HCC screening interval of 3 mo (P < 0.05). Seventy-one percent of doctors with an MD degree, 50% of doctors with a master degree or diploma and 60% of doctors with an MBBCH certificate follow the same recommendation.

CONCLUSION

In Egypt, physicians specialized in tropical medicine, internal medicine or gastroenterology with an MD degree and working in a University Hospital are best informed about HCC.

摘要

目的

评估埃及医生对肝细胞癌(HCC)患者进行筛查的实际情况。

方法

该研究纳入了来自埃及各地的154名负责照顾HCC高危患者的医生。该研究基于一份包含20个条目的问卷。每份问卷由两部分组成:(1)医生的个人信息(姓名、年龄、专业和医疗保健机构类型);(2)在照顾HCC发生高危患者方面的专业经验(筛查、对肝脏疾病病因和自然病程以及HCC风险的了解)。

结果

68%拥有医学博士学位的医生、48%拥有硕士学位或文凭的医生以及40%拥有医学学士和外科学士证书的医生认为丙型肝炎病毒(HCV)基因型是HCC发生的危险因素(P<0.05)。90%专门从事热带医学、内科或胃肠病学的医生以及67%其他专业的医生建议患者接受HCV和乙型肝炎病毒感染以及肝硬化的筛查(P<0.05)。86%大学医院的医生和69%卫生部(MOH)的医生认为HCV感染是埃及HCC的主要病因(P<0.05)。72%拥有医学博士学位的医生、55%拥有硕士学位或文凭的医生、56%拥有医学学士和外科学士证书的医生、74%大学医院的医生以及46%卫生部医院的医生认为腹部超声检查是HCC筛查中最重要的检查(P<0.05)。65%从事热带医学、内科或胃肠病学的医生以及37%其他专业的医生建议HCC筛查间隔为3个月(P<0.05)。71%拥有医学博士学位的医生、50%拥有硕士学位或文凭的医生以及60%拥有医学学士和外科学士证书的医生遵循相同的建议。

结论

在埃及,拥有医学博士学位、在大学医院工作、专门从事热带医学、内科或胃肠病学的医生对HCC的了解最为充分。

相似文献

1
Screening for hepatocellular carcinoma by Egyptian physicians.
World J Gastrointest Oncol. 2015 Sep 15;7(9):161-71. doi: 10.4251/wjgo.v7.i9.161.
2
Do Legal Issues Deserve Space in Specialty Medical Journals ?
J Assoc Physicians India. 2016 Feb;64(2):86-87.
3
Perspectives of physicians regarding screening patients at risk of hepatocellular carcinoma.
Gastroenterol Rep (Oxf). 2016 Aug;4(3):237-40. doi: 10.1093/gastro/gou089. Epub 2015 Jan 5.
4
Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study.
J Egypt Natl Canc Inst. 2016 Dec;28(4):257-262. doi: 10.1016/j.jnci.2016.06.001. Epub 2016 Jul 1.
7
Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Mutat Res. 2008 Jul-Aug;659(1-2):176-84. doi: 10.1016/j.mrrev.2008.01.005. Epub 2008 Jan 20.
8
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
Arab J Gastroenterol. 2018 Mar;19(1):26-32. doi: 10.1016/j.ajg.2018.02.004. Epub 2018 Mar 3.
9
The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.
J Clin Gastroenterol. 2001 Aug;33(2):123-6. doi: 10.1097/00004836-200108000-00006.
10
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures.
World J Gastrointest Oncol. 2021 Dec 15;13(12):1919-1938. doi: 10.4251/wjgo.v13.i12.1919.

引用本文的文献

1
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.
J Hepatocell Carcinoma. 2023 Sep 18;10:1547-1571. doi: 10.2147/JHC.S404424. eCollection 2023.
2
Role of T-Helper 9 Cells in Chronic Hepatitis C-Infected Patients.
Viruses. 2018 Jun 24;10(7):341. doi: 10.3390/v10070341.

本文引用的文献

1
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
World J Hepatol. 2012 Sep 27;4(9):256-61. doi: 10.4254/wjh.v4.i9.256.
2
Hepatocellular carcinoma.
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
3
Management of hepatocellular carcinoma: an update.
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
4
Global cancer statistics.
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
5
Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.
Dig Dis Sci. 2011 Feb;56(2):569-77. doi: 10.1007/s10620-010-1453-5. Epub 2010 Oct 27.
6
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Eur J Cancer. 2010 Mar;46(4):744-51. doi: 10.1016/j.ejca.2009.12.018. Epub 2010 Jan 8.
7
Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
Clin Gastroenterol Hepatol. 2010 Feb;8(2):192-9. doi: 10.1016/j.cgh.2009.10.026. Epub 2009 Oct 30.
8
Chronic hepatitis B: update 2009.
Hepatology. 2009 Sep;50(3):661-2. doi: 10.1002/hep.23190.
9
Gender-based outcomes differences in unresectable hepatocellular carcinoma.
Hepatol Int. 2008 Mar;2(1):95-101. doi: 10.1007/s12072-007-9041-2. Epub 2007 Dec 15.
10
Causes of death in patients with unresectable hepatocellular carcinoma.
Dig Dis Sci. 2007 Nov;52(11):3285-9. doi: 10.1007/s10620-007-9750-3. Epub 2007 Apr 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验